Related Experiment Videos
Specific features of apoptosis in human lens epithelial cells induced by mitomycin C in vitro
J F Jordan1, N Kociok, S Grisanti
1University Eye Clinic, University of Cologne, Germany. j.jordan@uni-koeln.de
Background:
Posterior capsule opacification (PCO) is still one of the major complications following modern cataract surgery. Several attempts have been made to find an appropriate therapeutic concept to significantly lower the rate of PCO. Here, we wanted to focus on the antimetabolic strategy, reducing PCO by using mitomycin C, further characterizing the pathway of apoptosis in human lens epithelial cells (hLECs).
Methods:
Human lens epithelial cells were obtained from anterior lens capsules during cataract surgery. The expression of Fas, TRAMP, TRAIL-R1-R4, Apo-3L and TRAIL mRNA was investigated by means of RT-PCR using specific primers. For investigations on bcl-2, bax, p53 and the active form of caspase 3, cell cultures of hLECs were pretreated with mitomycin C and processed for immunocytochemistry thereafter.
Results:
We detected the expression of the receptors Fas, TRAMP, TRAIL-R2 and TRAIL-R3 in hLECs. We further obtained evidence of the upregulation of the intracellular apoptotic signalling cascade, represented by bcl-2 and bax, the transcription factor p53 and the active form of caspase 3, after pretreatment with mitomycin C.
Conclusion:
We demonstrated the presence of the apoptosis-receptor system in hLECs. Furthermore, we demonstrated the possibility of the induction of key proteins of the apoptotic signalling cascade in these cells by the antimetabolic drug mitomycin C. This could have important implications on the strategies regarding both the prevention and the treatment of PCO after cataract surgery.
Insights
Mitomycin C can induce apoptosis in human lens epithelial cells (hLECs) by activating key proteins. This finding offers new strategies for preventing and treating posterior capsule opacification (PCO) after cataract surgery.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Posterior capsule opacification (PCO) remains a significant complication of cataract surgery.
- Current therapeutic strategies for PCO are limited.
- Investigating antimetabolic agents like mitomycin C offers a potential avenue for PCO management.
Purpose of the Study:
- To investigate the efficacy of mitomycin C in reducing PCO.
- To characterize the apoptosis pathway in human lens epithelial cells (hLECs) treated with mitomycin C.
Main Methods:
- Human lens epithelial cells (hLECs) were isolated from anterior lens capsules.
- Reverse transcription-polymerase chain reaction (RT-PCR) was used to analyze mRNA expression of apoptosis-related genes.
- Immunocytochemistry was employed to assess protein expression after mitomycin C treatment.
Main Results:
- Expression of apoptosis receptors (Fas, TRAMP, TRAIL-R2, TRAIL-R3) was detected in hLECs.
- Mitomycin C treatment upregulated key apoptotic signaling proteins, including bcl-2, bax, p53, and active caspase 3.
- Evidence suggests mitomycin C activates intracellular apoptotic cascades in hLECs.
Conclusions:
- Human lens epithelial cells (hLECs) possess a functional apoptosis-receptor system.
- The antimetabolic drug mitomycin C can induce apoptosis in hLECs by activating key signaling proteins.
- These findings have significant implications for developing novel strategies for PCO prevention and treatment.